Most Popular in the Last...

Johns Hopkins Launches iWatch Epilepsy App for Open Source ResearchKit
Diverse Open Source Uses Highlight Need For Precision In Cyber Resilience Act
Wyoming Awards Contract to SLI Global Solutions for IV&V of Medicaid Systems Modernization Project
VistA Is A Rival to Epic and Cerner in Major Deployments of EHR Systems
Artificial Intelligence Cluster Modeling on COVID-19 Data at Scale Offers Opportunity for Improved Patient Outcomes
Getting Started With Carbonio, An Open Source Collaboration Platform
Understanding the Cyber Resilience Act: What Everyone involved in Open Source Development Should Know
The Appeal of Graph Databases for Health Care
Benefits, Challenges and Best Practices of Clinical Trials: Paper vs. Electronic Data Capture
Open Source Resources for major Disaster & Emergency Management Situations

Malaria Box

See the following -

Advancing Antimalarial Drug Research Through Open Source Initiatives

Jeremy Burrows | The Guardian | July 24, 2013

Open research can lead to new drugs tackling diseases that afflict the world's poor. But first, more scientists need to buy into contributing to something bigger than their careers Read More »

Griffith Scientists Unlock the “Malaria Box”

Press Release | Griffith University | August 1, 2016

A “Malaria Box” that could hold the answer to discovering new drugs to treat tropical diseases and cancer has been created for researchers around the world. Griffith University tropical disease researchers have joined together with a host of international laboratories to advance drug discovery for major topical diseases through the creation and testing of the Malaria Box. In a paper published this week in the top journal PLoS Pathogens, the global team present findings on a panel of 400 chemical compounds – dubbed the “Malaria Box” – with potential application as therapeutic starting points for diseases like malaria, trypanosomiasis and toxoplasmosis.

Read More »

Open Access Initiative Reveals Drug Hits For Deadly Neglected Tropical Diseases

Press Release | Drugs for Neglected Diseases initiative (DNDi), Medicines for Malaria Venture (MMV) | November 13, 2012

The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases (NTDs), through DNDi’s screening of MMV’s open access Malaria Box. Read More »

Recent Research Highlights Potential Of Open Access In Drug Discovery

Rachel Marusak Hermann | Intellectual Property Watch | November 14, 2012

The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announced the identification of three potential drug classes for the treatment of neglected tropical diseases through the availability of hundreds of compounds in the public domain. Read More »

Top Menu